Related Experiment Videos
Phylogenetic internal control for HIV-1 genotypic antiretroviral testing
E Boeri1, F Canducci, M A Grasso
1Diagnostica & Ricerca San Raffaele, Milano, Italia.
The New Microbiologica
|January 14, 2005
Summary
Phylogenetic analysis of viral sequences provides robust quality control for genotypic testing. This method effectively identifies sample mix-ups and confirms patient identity, even with significant drug resistance mutations.
Area of Science:
- Molecular Biology
- Virology
- Bioinformatics
Background:
- Genotypic testing for viral infections involves multiple critical steps requiring rigorous quality control.
- Established internal controls for RNA purification, RT-PCR, DNA sequencing, and analysis are essential.
- An additional phylogenetic quality control step can enhance the reliability of genotypic testing.
Purpose of the Study:
- To introduce and validate a phylogenetic quality control method for genotypic testing.
- To assess the utility of phylogenetic analysis in preventing sample mix-ups.
- To confirm the accurate assignment of viral sequences to individual patients, even with high divergence.
Main Methods:
- Routine comparison of new viral sequences with previous samples from the same patient using multiple alignment.
- Construction of neighbor-joining trees with the Kimura two-parameter method.
- Analysis of reverse transcriptase and protease gene sequences from 30 wild-type viral samples and longitudinal samples from 5 patients.
Main Results:
- Nucleotide sequence analysis demonstrated a mean inter-sample divergence of 2.9% in wild-type sequences.
- All sequence pairs from individual patients consistently clustered together in trees based on nucleotide sequences.
- Amino acid sequence-based trees did not always reliably cluster sequences from the same patient.
Conclusions:
- Phylogenetic analysis of nucleic acid sequences is a valuable tool for detecting sample mix-ups in genotypic testing.
- This method reliably confirms sequence origin from individual patients, irrespective of drug resistance mutations.
- Nucleotide sequence-based phylogenetic analysis offers superior accuracy for patient-specific sequence identification compared to amino acid analysis.